{
  "pmcid": "10106358",
  "sha256": "e088e299e05d933ee0d639d5aec3a26af9318f29d62ecc9c60ae906e6dafc31c",
  "timestamp_utc": "2025-11-09T21:51:38.330635+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.54630434782609,
    "reading_ease": 25.594673913043493,
    "word_count": 230
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Intrathecal Oxytocin for Postoperative Recovery: A Randomised Controlled Trial"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "98 participants undergoing elective total hip arthroplasty were randomised"
      },
      "Participants": {
        "score": 2,
        "evidence": "98 participants undergoing elective total hip arthroplasty"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomised to receive either intrathecal oxytocin (100 μg) or saline"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluated whether intrathecal oxytocin accelerates recovery from pain and disability after major surgery."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the modelled pain trajectory, assessed from the day of hospital discharge over 8 weeks."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was computer-generated, with allocation concealed."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Participants, clinicians, and outcome assessors were blinded."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "98 participants undergoing elective total hip arthroplasty were randomised"
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Ninety patients were analysed (oxytocin: n=44; saline: n=46) using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The primary outcome showed no significant difference in pain trajectory between groups (intercept: −0.1, 95% CI: −0.8 to 0.6, p=0.746; slope: 0.1, 95% CI: 0 to 0.2, p=0.057)."
      },
      "Harms": {
        "score": 1,
        "evidence": "No drug-related adverse effects were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 1,
        "evidence": "The study was stopped early due to lack of funding."
      }
    },
    "total_score": 22,
    "max_score": 25
  }
}